Pertussis re-emergence in the post-vaccination era (Q34636630)

3 August 2017

8 references

23 March 2019

20 June 2019

25 June 2019

22 July 2019

4 August 2019

19 September 2019

28 May 2020

1 August 2020

Pertussis re-emergence in the post-vaccination era (English)

1 reference

preventive health services

3 August 2017

0 references

1 reference

22 July 2019

1 reference

4 August 2019

3 references

19 September 2019

28 May 2020

1 August 2020

biomedical investigative technique

1 reference

emerging communicable disease

19 September 2019

1 reference

1 August 2020

Elena Chiappini

1

0 references

author name string

Alessia Stival

series ordinal

2

1 reference

3 August 2017

Luisa Galli

series ordinal

3

1 reference

3 August 2017

Maurizio de Martino

series ordinal

4

1 reference

3 August 2017

publication date

26 March 2013

9 references

3 August 2017

23 March 2019

20 June 2019

25 June 2019

22 July 2019

4 August 2019

19 September 2019

28 May 2020

1 August 2020

BMC Infectious Diseases

9 references

3 August 2017

23 March 2019

20 June 2019

25 June 2019

22 July 2019

4 August 2019

19 September 2019

28 May 2020

1 August 2020

13

1 reference

3 August 2017

page(s)

151

1 reference

Creative Commons Attribution 2.0 Generic

3 August 2017

copyright license

8 references

23 March 2019

20 June 2019

25 June 2019

22 July 2019

4 August 2019

19 September 2019

28 May 2020

Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (boostrix(®)): a guide to its use as a single-dose booster immunization against pertussis

1 August 2020

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around....

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Re-emergence of pertussis: what are the solutions?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Can infants be protected by means of maternal vaccination?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

New pertussis vaccination approaches: en route to protect newborns?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Prevention of pertussis, tetanus, and diphtheria among pregnant, postpartum women, and infants

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

A critical literature review of health economic evaluations in pertussis booster vaccination

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Accelerating control of pertussis in England and Wales

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Rationale for pertussis booster vaccination throughout life in Europe.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Booster vaccination after neonatal priming with acellular pertussis vaccine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, suppo

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Resurgence of pertussis in Europe

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

California pertussis epidemic, 2010.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Pregnant women in UK are offered whooping cough vaccine to protect newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Efficacy of an acellular pertussis vaccine among adolescents and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Pertussis vaccine effectiveness after mass immunization of high school students in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Effect of a Prepregnancy Pertussis Booster Dose on Maternal Antibody Titers in Young Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

The reemergence of pertussis and infant deaths: is it time to immunize pregnant women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Immunogenicity of a three-component acellular pertussis vaccine administered at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Transmission of Bordetella pertussis to young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Pertussis cocoon strategy: would it be useful for Latin America and other developing countries?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Waning protection after fifth dose of acellular pertussis vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Early Impact of the US Tdap vaccination program on pertussis trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Meeting of the Strategic Advisory Group of Experts on immunization, October 2009--Conclusions and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Cost-effectiveness of pertussis booster vaccination in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Cost effectiveness of pertussis vaccination in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623740

Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women

26 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

The Number Needed to Vaccinate to Prevent Infant Pertussis Hospitalization and Death Through Parent Cocoon Immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-151

Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age

21 January 2018

1 reference

12 December 2020

Infant pertussis: what to do next?

1 reference

12 December 2020

Pertussis outbreaks and pertussis vaccines: new insights, new concerns, new recommendations?

1 reference

12 December 2020

Resource consumption in the infection control management of pertussis exposure among healthcare workers in pediatrics

1 reference

12 December 2020

Why do pertussis vaccines fail?

1 reference

12 December 2020

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001

1 reference

12 December 2020

Pertussis immunization in a high-risk postpartum population

1 reference

12 December 2020

Pertussis epidemic--Washington, 2012

1 reference

12 December 2020

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine

1 reference

12 December 2020

Infant pertussis: is cocooning the answer?

1 reference

12 December 2020

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012

1 reference

12 December 2020

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Im

1 reference

12 December 2020

The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids

1 reference

12 December 2020

Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants

1 reference

12 December 2020

Pertussis cases rise 10-fold among older children and adults in England and Wales

1 reference

12 December 2020

Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels

1 reference

12 December 2020

Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina

1 reference

12 December 2020

[Vaccination coverage among health care workers in the pediatric emergency and intensive care department of Edouard Herriot hospital in 2007, against influenza, pertussis, varicella, and measles]

1 reference

12 December 2020

Nosocomial infections and community clusters of pertussis in France, 2000-2005

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-13-151

1 reference

3 August 2017

1 reference

3 August 2017

1 reference